跳至主要内容
临床试验/CTRI/2024/10/075501
CTRI/2024/10/075501尚未招募3 期

Comparison of efficacy and tolerability of levetiracetam and valproate for newly diagnosed generalised and unclassifiable epilepsy in adolescent girls aged 10-18 years: a randomized controlled trial

Dr Suthiraj S1 个研究点 分布在 1 个国家目标入组 302 人开始时间: 2024年10月31日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
302
试验地点
1
主要终点
Number of participants with seizure freedom

研究概览

简要总结

In this RCT we want to compare the efficacy and tolerability of two commonly used anti-seizure medications; valproate and levetiracetam in adolecsent girls with generalized and unclassifiable epilepsy aged 10-18 years. Both drugs will be administered to participants for 24 weeks and we will compare the number of patienst with seizure freedom and adverse effects in both groups.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
10.00 Year(s) 至 18.00 Year(s)(—)
性别
Female

入选标准

  • 1.Newly diagnosed case of generalized or unclassifiable epilepsy 2.History of at least one convulsive seizure within previous one month.

排除标准

  • Parents not providing informed consent
  • Adolescent suffering fromc hronic hepatic or renal disease
  • Only acute symptomatic seizures.

结局指标

主要结局

Number of participants with seizure freedom

时间窗: At 24 weeks

次要结局

  • Number of participants with any adverse effect due to study medication(24 weeks)

研究者

发起方
Dr Suthiraj S
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Suthiraj S

AIIMS, Rishikesh

研究点 (1)

Loading locations...

相似试验